EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation

Katyna Sada Del Real iD, Vinay S Swamy, Josefina Arcagni iD, Eric Wang, Raul Rabadan iD, Angel Rubio iD

Briefings in Bioinformatics · 2026

DOI: 10.1093/bib/bbag225 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Briefings in Bioinformatics, 2026. Verfasst von Katyna Sada Del Real und 5 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Ingeniería Biomédica y Ciencias, TECNUN, Universidad de Navarra, Paseo de Manuel Lardizábal 13, 20018 San Sebastián, Gipuzkoa, Spain. Hauptthemen laut MEDLINE: Deep Learning, Antineoplastic Agents, Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 71 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Cancer Research UK.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of large-scale omics data and foundational models has renewed efforts in the field of cancer drug response prediction (DRP). Despite recent progress, challenges such as limited tumor heterogeneity in standard cell lines and inconsistencies in experimental protocols across studies persist. However, these challenges also open significant opportunities for innovation. The complex nature of drug responses, influenced by variations in new patients and new drugs, presents a critical area for advancing validation approaches that traditional machine learning approaches often overlook. This review provides a comprehensive overview of the current state of DRP using advanced machine-learning models, discussing data sources, model designs, and evaluation methods. We introduce a unified framework for testing these models with a focus on clinically relevant metrics. By evaluating a range of foundational and deep-learning models within this framework, we identify performance gaps and propose concrete strategies to advance these computational models for reliable use in personalized cancer treatment, thereby unlocking their full clinical potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Deep LearningAntineoplastic AgentsNeoplasmsHumansPredictive Learning ModelsComputational BiologyPrediction Algorithms

Stichwörter der Autor:innen

cancer drug responseframeworkmachine learningmetrics

Substanzen

Antineoplastic Agents

Autor:innen und Institutionen

  • Departamento de Ingeniería Biomédica y Ciencias, TECNUN, Universidad de Navarra, Paseo de Manuel Lardizábal 13, 20018 San Sebastián, Gipuzkoa, Spain.
  • Department of Biomedical Informatics, Columbia University, 622 West 168th Street, Washington Heights, New York, NY 10032, United States.
  • Google DeepMind, 1600 Amphitheatre Parkway, North Bayshore, Mountain View, CA 94043, United States.
  • Instituto de Ciencia de Datos e Inteligencia Artificial (DATAI), Universidad de Navarra, 31080 Pamplona, Spain.

ORCID-Profile: Katyna Sada Del Real, Josefina Arcagni, Raul Rabadan, Angel Rubio

Förderung

  • Cancer Research UK

Zitieren

APA

Sada Del Real, K., Swamy, V. S., Arcagni, J., Wang, E., Rabadan, R., & Rubio, A. (2026). Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation. Briefings in Bioinformatics. https://doi.org/10.1093/bib/bbag225

Vancouver

Sada Del Real K, Swamy VS, Arcagni J, Wang E, Rabadan R, Rubio A. Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation. Briefings in Bioinformatics. 2026. doi:10.1093/bib/bbag225

BibTeX
@article{SadaDelReal2026,
  author = {Sada Del Real, Katyna and Swamy, Vinay S and Arcagni, Josefina and Wang, Eric and Rabadan, Raul and Rubio, Angel},
  title = {Foundation models and deep learning for cancer drug response prediction: a framework for data, metrics, and validation},
  journal = {Briefings in Bioinformatics},
  year = {2026},
  doi = {10.1093/bib/bbag225}
}
Kostenlos starten →